V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240015788 | 240015349 | null | 89.8 | Palliative (P) | 2017-12-02 | 2017-12-02 | Cytarabine low (10to20mg/m2) IV/SC | 2 | N | 240033173 | METHOTREXATE |
| 240015789 | 240008127 | 1.75 | 53 | Palliative (P) | 2015-03-06 | 2018-04-14 | Cyclophosphamide + Dex + Rituximab | N | N | 240033188 | BENDAMUSTINE |
| 240015790 | 240012361 | 1.69 | 73.6 | null | 2016-05-21 | 2016-06-30 | TRASTUZUMAB | N | N | 240033272 | IBRUTINIB |
| 240015791 | 240014348 | 1.78 | null | null | 2015-03-30 | 2015-04-01 | GEMCITABINE | 02 | N | 240033321 | METHOTREXATE |
| 240015792 | 240008159 | null | 5.82 | Disease modification (D) | 2015-09-11 | 2015-09-11 | R IVAC | 2 | N | 240033356 | METHOTREXATE |
| 240015793 | 240012372 | 1.63 | 72 | Curative (C) | 2015-08-15 | 2017-02-01 | Bortezomib (weekly) | 2 | N | 240033393 | GEMCITABINE |
| 240015794 | 240008167 | 1.6 | 66 | Palliative (P) | 2019-06-30 | 2019-12-29 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | N | 240033450 | CARBOPLATIN + ETOPOSIDE |
| 240015795 | 240012378 | 1.66 | null | Curative (C) | 2014-10-14 | 2015-01-24 | CHLORAMBUCIL + RITUXIMAB | N | N | 240033485 | CHLORAMBUCIL + RITUXIMAB |
| 240015796 | 240008185 | 1.83 | 101 | Palliative (P) | null | 2016-10-06 | Bendamustine +/- Prednisolone | N | N | 240033543 | CYCLOPHOSPHAMIDE |
| 240015797 | 240008193 | 1.57 | 82.3 | Disease modification (D) | 2016-09-06 | 2016-09-07 | R Chlorambucil | N | null | 240033580 | CHLORAMBUCIL + RITUXIMAB |
| 240015798 | 240008198 | 1.61 | 57.3 | Palliative (P) | 2019-09-06 | 2019-09-09 | BEAM | 2 | N | 240033611 | IBRUTINIB |
| 240015799 | 240008203 | 1.7 | null | Curative (C) | 2018-03-28 | 2018-03-30 | Bortezomib +/- Dexamethasone | 02 | N | 240033648 | BORTEZOMIB |
| 240015800 | 240008207 | 1.65 | 52 | Palliative (P) | 2014-10-14 | 2016-02-12 | Methotrexate High Dose (3g/m2) | 2 | N | 240033661 | LENALIDOMIDE |
| 240015801 | 240012397 | null | 72 | Curative (C) | 2015-11-22 | 2015-12-10 | Bortezomib (weekly) | N | N | 240033684 | DHAP |
| 240015802 | 240008220 | null | 69.7 | Palliative (P) | 2015-11-16 | 2015-11-17 | R Chlorambucil | 2 | N | 240033717 | CHLORAMBUCIL + RITUXIMAB |
| 240015803 | 240008234 | 1.81 | 83 | null | 2018-05-06 | 2018-05-18 | Brentuximab | 02 | N | 240033833 | BRENTUXIMAB |
| 240015804 | 240008254 | 1.53 | 55.6 | Palliative (P) | 2016-01-10 | 2016-03-14 | DA 3+8 | 2 | N | 240033963 | CYCLOPHOSPHAMIDE |
| 240015805 | 240012425 | 1.64 | null | Palliative (P) | 2019-07-20 | 2019-07-27 | Cyclophosphamide High Dose | N | N | 240034019 | LEAM |
| 240015806 | 240014374 | 1.69 | null | Palliative (P) | 2017-08-14 | 2017-08-15 | Cyclophosphamide High Dose | N | N | 240034046 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 240015807 | 240008278 | null | 59 | Curative (C) | 2015-03-10 | 2015-03-13 | Cyclophosphamide High Dose | 02 | N | 240034120 | BENDAMUSTINE |
| 240015808 | 240008281 | null | 104 | null | 2018-09-04 | 2018-09-05 | CYTARABINE | 2 | null | 240034124 | GEMCITABINE |
| 240015809 | 240008285 | 1.63 | 71.6 | Curative (C) | 2019-02-19 | 2019-02-19 | Cisplatin + Topotecan | N | N | 240034144 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 240015810 | 240008289 | 1.8 | 0 | null | 2015-04-30 | 2015-07-02 | ABVD | N | N | 240034148 | DHAP |
| 240015811 | 240008297 | null | 65.3 | Curative (C) | 2015-03-12 | 2015-03-16 | Brentuximab | N | N | 240034166 | BRENTUXIMAB |
| 240015812 | 240008300 | 1.73 | 65.5 | Adjuvant (A) | 2018-09-03 | 2018-09-04 | Bortezomib +/- Dexamethasone | N | null | 240034176 | CARBOPLATIN + ETOPOSIDE |
| 240015813 | 240008304 | 1.61 | 95.9 | Palliative (P) | 2018-05-17 | 2018-07-02 | Methotrexate Intermed dose (1g/m2) | N | N | 240034188 | CARBOPLATIN + ETOPOSIDE |
| 240015814 | 240008313 | 1.7 | 90.8 | Curative (C) | 2018-09-26 | 2018-09-26 | BEAM | null | Y | 240034260 | GEMCITABINE |
| 240015815 | 240008319 | 1.82 | 79.6 | Curative (C) | 2019-04-07 | 2019-07-16 | CYCLOPHOSPHAMIDE + RITUXIMAB | 02 | null | 240034311 | GDP |
| 240015816 | 240008323 | 1.68 | 77.2 | Curative (C) | 2016-05-28 | 2016-06-05 | LEAM | null | null | 240034321 | METHOTREXATE |
| 240015817 | 240008325 | 1.52 | 72 | null | 2013-06-28 | 2013-10-02 | LEAM | 2 | N | 240034332 | BORTEZOMIB |
| 240015818 | 240008329 | 1.58 | 91.9 | Curative (C) | 2017-01-27 | 2017-02-04 | CYCLOPHOSPHAMIDE + MESNA | null | null | 240034344 | TRASTUZUMAB |
| 240015819 | 240008335 | 1.65 | 62.4 | Palliative (P) | 2018-06-30 | 2018-08-14 | CISPLATIN + ETOPOSIDE | 02 | N | 240034384 | HYDROXYCARBAMIDE |
| 240015820 | 240008343 | 1.61 | 59.8 | Curative (C) | 2014-06-08 | 2014-06-08 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | N | N | 240034422 | METHOTREXATE |
| 240015821 | 240008349 | 0 | 82.7 | Disease modification (D) | 2018-10-17 | 2018-10-22 | R Chlorambucil | 02 | null | 240034478 | CHLORAMBUCIL + RITUXIMAB |
| 240015822 | 240008351 | 1.64 | 42.6 | Palliative (P) | 2013-12-17 | 2013-12-18 | R Chlorambucil | 02 | N | 240034485 | CHLORAMBUCIL + RITUXIMAB |
| 240015823 | 240015877 | 1.65 | null | Palliative (P) | 2018-09-07 | 2018-09-10 | CYCLOPHOSPHAMIDE + RITUXIMAB | 01 | N | 240034537 | METHOTREXATE HIGH DOSE |
| 240015824 | 240008370 | 1.63 | 77.8 | Curative (C) | 2016-03-01 | 2016-03-02 | Chlorambucil | N | N | 240034540 | CHLORAMBUCIL |
| 240015825 | 240012480 | null | 110.8 | Palliative (P) | 2018-07-30 | 2018-10-27 | ABVD | 2 | N | 240034558 | FLAG + IDARUBICIN |
| 240015826 | 240008378 | 1.75 | 75.5 | Adjuvant (A) | 2015-05-09 | 2015-05-12 | Alemtuz+Fludara+Melphalan RIC MUD | 2 | N | 240034564 | CISPLATIN + TOPOTECAN |
| 240015827 | 240012483 | null | 72.6 | Curative (C) | 2017-05-02 | 2017-05-10 | Hydroxycarbamide | N | N | 240034593 | GDP |
| 240015828 | 240008384 | 1.85 | 108 | Curative (C) | 2013-07-14 | 2013-10-13 | CARBOPLATIN + GEMCITABINE | N | N | 240034689 | METHOTREXATE HIGH DOSE |
| 240015829 | 240012490 | 1.65 | null | Curative (C) | 2016-04-08 | 2016-05-19 | GEMCITABINE | 02 | N | 240034744 | GDP |
| 240015830 | 240008400 | null | 76.6 | null | 2017-01-29 | 2017-02-06 | Carboplatin + Etoposide IV 3 day | 01 | N | 240034778 | FCR |
| 240015831 | 240008405 | 1.75 | null | Palliative (P) | null | 2017-07-06 | Cisplatin + Topotecan | 02 | N | 240034784 | IBRUTINIB |
| 240015832 | 240008412 | null | 89.8 | Palliative (P) | 2014-05-10 | 2014-05-12 | Methotrexate Intermed dose (1g/m2) | N | N | 240034846 | HYDROXYCARBAMIDE |
| 240015833 | 240012505 | 1.68 | 62.35 | Palliative (P) | null | 2016-12-18 | METHOTREXATE | N | N | 240034917 | R IVAC |
| 240015834 | 240008433 | 1.69 | 70.4 | Palliative (P) | 2015-09-28 | 2015-10-01 | Chlorambucil | 2 | N | 240035016 | CHLORAMBUCIL |
| 240015835 | 240008444 | null | null | Palliative (P) | 2014-01-13 | 2014-01-19 | R IVAC | 02 | N | 240035100 | BEAM |
| 240015836 | 240008447 | 1.56 | 55.8 | Disease modification (D) | 2016-01-11 | 2016-01-15 | R Chlorambucil | 02 | N | 240035106 | CHLORAMBUCIL + RITUXIMAB |
| 240015837 | 240008450 | null | 56.8 | null | 2014-06-23 | 2014-06-25 | ABVD | N | N | 240035134 | CYCLOPHOSPHAMIDE + RITUXIMAB |